Catherine L.R. Merry

4.6k total citations
84 papers, 3.6k citations indexed

About

Catherine L.R. Merry is a scholar working on Molecular Biology, Cell Biology and Infectious Diseases. According to data from OpenAlex, Catherine L.R. Merry has authored 84 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 36 papers in Cell Biology and 11 papers in Infectious Diseases. Recurrent topics in Catherine L.R. Merry's work include Proteoglycans and glycosaminoglycans research (32 papers), Glycosylation and Glycoproteins Research (18 papers) and Fibroblast Growth Factor Research (8 papers). Catherine L.R. Merry is often cited by papers focused on Proteoglycans and glycosaminoglycans research (32 papers), Glycosylation and Glycoproteins Research (18 papers) and Fibroblast Growth Factor Research (8 papers). Catherine L.R. Merry collaborates with scholars based in United Kingdom, United States and Ireland. Catherine L.R. Merry's co-authors include John T. Gallagher, Rebecca Holley, Christopher M. Ward, Sarah Ritson, Malcolm Lyon, Francesca Soncin, Valerie Wilson, Toin H. Van Kuppevelt, Claire E. Pickford and Peter L. Stern and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Catherine L.R. Merry

82 papers receiving 3.6k citations

Peers

Countries citing papers authored by Catherine L.R. Merry

Since Specialization

Citations

This map shows the geographic impact of Catherine L.R. Merry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine L.R. Merry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine L.R. Merry more than expected).

Fields of papers citing papers by Catherine L.R. Merry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine L.R. Merry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine L.R. Merry. The network helps show where Catherine L.R. Merry may publish in the future.

Co-authorship network of co-authors of Catherine L.R. Merry

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine L.R. Merry. A scholar is included among the top collaborators of Catherine L.R. Merry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine L.R. Merry. Catherine L.R. Merry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integrin‐Piezo1 Axis Drives ECM Remodeling and Invasion of 3D Breast Epithelium 2025 ·Advanced Science ·(unknown), (unknown), Zhimeng Fan, (unknown), Catherine L.R. Merry, Pontus Nordenfelt, Adam Cohen Simonsen, Amanda J. Wright, Vinay Swaminathan	0
2	Application of a 3D hydrogel-based model to replace use of animals for passaging patient-derived xenografts 2023 ·PubMed ·S J Jones, J. Ashworth, (unknown), (unknown), (unknown), Alison Ritchie, Catherine L.R. Merry, Anna M. Grabowska	5
3	Identifying new biomarkers of aggressive Group 3 and SHH medulloblastoma using 3D hydrogel models, single cell RNA sequencing and 3D OrbiSIMS imaging 2023 ·Acta Neuropathologica Communications ·Franziska Linke, (unknown), Stefanie Kern, (unknown), Anbarasu Lourdusamy, (unknown), Steven C. Clifford, Catherine L.R. Merry, Snow Stolnik, Morgan R. Alexander, Andrew C. Peet, David J. Scurr, Rian L. Griffiths, Anna M. Grabowska, Ian D. Kerr, Beth Coyle	15
4	High sensitivity analysis of nanogram quantities of glycosaminoglycans using ToF-SIMS 2021 ·Communications Chemistry ·Andrew L. Hook, John Hogwood, Elaine Gray, Barbara Mulloy, Catherine L.R. Merry	17
5	Self-assembling peptide hydrogel for intervertebral disc tissue engineering 2016 ·Acta Biomaterialia ·Simon Wan, (unknown), Stephen M. Richardson, Catherine L.R. Merry, Alberto Saiani, Julie E. Gough	111
6	Use of Flow Cytometry for Characterization and Fractionation of Cell Populations Based on Their Expression of Heparan Sulfate Epitopes 2014 ·Methods in molecular biology ·Rebecca Holley, Raymond A. Smith, Els M.A. van de Westerlo, Claire E. Pickford, Catherine L.R. Merry, Toin H. Van Kuppevelt	3
7	Rigid versus semi-rigid orthotic use following TMC arthroplasty: A randomized controlled trial 2014 ·Journal of Hand Therapy ·Rosemary Prosser, Mark J. Hancock, Leslie L. Nicholson, Catherine L.R. Merry, (unknown), (unknown)	8
8	Myeloid/Microglial Driven Autologous Hematopoietic Stem Cell Gene Therapy Corrects a Neuronopathic Lysosomal Disease 2013 ·Molecular Therapy ·(unknown), Alex Langford-Smith, (unknown), Claire E. Pickford, John McDermott, (unknown), Kia Langford‐Smith, Catherine L.R. Merry, Simon Jones, J. E. Wraith, Robert Wynn, Fiona L. Wilkinson, Brian Bigger	99
9	Neuropathology in Mouse Models of Mucopolysaccharidosis Type I, IIIA and IIIB 2012 ·PLoS ONE ·Fiona L. Wilkinson, Rebecca Holley, Kia Langford‐Smith, S Badrinath, Aiyin Liao, Alex Langford-Smith, Jonathan D. Cooper, Simon Jones, J. E. Wraith, Robert Wynn, Catherine L.R. Merry, Brian Bigger	145
10	Immobilization of Heparan Sulfate on Electrospun Meshes to Support Embryonic Stem Cell Culture and Differentiation * 2012 ·Journal of Biological Chemistry ·(unknown), Kate White, Claire E. Pickford, Rebecca Holley, Andrew Marson, (unknown), Toin H. Van Kuppevelt, Jason D. Whittle, Anthony J. Day, Catherine L.R. Merry	33
11	Hematopoietic Stem Cell and Gene Therapy Corrects Primary Neuropathology and Behavior in Mucopolysaccharidosis IIIA Mice 2012 ·Molecular Therapy ·Alex Langford-Smith, Fiona L. Wilkinson, Kia Langford‐Smith, Rebecca Holley, (unknown), (unknown), William Bennett, Simon Jones, (unknown), Catherine L.R. Merry, Robert Wynn, Brian Bigger	86
12	Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults 2012 ·Journal of Antimicrobial Chemotherapy ·Pauline Byakika‐Kibwika, Mohammed Lamorde, (unknown), Harriet Mayanja‐Kizza, Elly Katabira, Warunee Hanpithakpong, Nadine G. Pakker, Thomas P. C. Dorlo, Joel Tärning, Niklas Lindegårdh, Peter J. de Vries, David Back, Saye Khoo, Catherine L.R. Merry	38
13	Mapping the Differential Distribution of Glycosaminoglycans in the Adult Human Retina, Choroid, and Sclera 2011 ·Investigative Ophthalmology & Visual Science ·Simon J. Clark, Tiarnán D L Keenan, (unknown), (unknown), Rebecca Holley, Catherine L.R. Merry, Toin H. Van Kuppevelt, Anthony J. Day, Richard D. Unwin	111
14	E-Cadherin Acts as a Regulator of Transcripts Associated with a Wide Range of Cellular Processes in Mouse Embryonic Stem Cells 2011 ·PLoS ONE ·Francesca Soncin, Lisa Mohamet, Sarah Ritson, Kate Hawkins, Nicoletta Bobola, Leo Zeef, Catherine L.R. Merry, Christopher M. Ward	24
15	Influencing Hematopoietic Differentiation of Mouse Embryonic Stem Cells using Soluble Heparin and Heparan Sulfate Saccharides 2010 ·Journal of Biological Chemistry ·Rebecca Holley, Claire E. Pickford, Graham Rushton, Georges Lacaud, John T. Gallagher, Valérie Kouskoff, Catherine L.R. Merry	41
16	Nevirapine pharmacokinetics when initiated at 200 mg or 400 mg daily in HIV-1 and tuberculosis co-infected Ugandan adults on rifampicin 2010 ·Journal of Antimicrobial Chemotherapy ·Mohammed Lamorde, Pauline Byakika‐Kibwika, (unknown), Máirín Ryan, Peter Coakley, Marta Boffito, (unknown), Francis Kalemeera, Robert Colebunders, D.J. Back, SH Khoo, Catherine L.R. Merry	14
17	A Developmentally Regulated Heparan Sulfate Epitope Defines a Subpopulation with Increased Blood Potential During Mesodermal Differentiation 2008 ·Stem Cells ·(unknown), Gerdy B. ten Dam, Toin H. Van Kuppevelt, Georges Lacaud, John T. Gallagher, Valérie Kouskoff, Catherine L.R. Merry	40
18	Controlling cell morphology on amino acid-modified cellulose 2008 ·Soft Matter ·Deepak M. Kalaskar, Julie E. Gough, Rein V. Ulijn, William W. Sampson, David J. Scurr, Frank J. M. Rutten, Morgan R. Alexander, Catherine L.R. Merry, Stephen J. Eichhorn	23
19	Healthcare worker crisis in Africa jeopardises the fight against HIV/AIDS. 2005 ·PubMed ·Máirín Ryan, (unknown), Peter Coakley, Catherine L.R. Merry	1
20	Simultaneous outbreaks of two strains of toxigenic Clostridium difficile in a general hospital 1998 ·Journal of Hospital Infection ·Lorraine Kyne, Catherine L.R. Merry, Brian O’Connell, Patricia Harrington, C. Keane, Desmond O’Neill	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact